PARK AVENUE SECURITIES LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARK AVENUE SECURITIES LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,064
+6.0%
30,083
+5.0%
0.05%
+2.2%
Q2 2023$2,890
+32.9%
28,641
+21.2%
0.05%
+24.3%
Q1 2023$2,174
-99.9%
23,625
-0.9%
0.04%
-2.6%
Q4 2022$2,163,000
-99.9%
23,844
+14.9%
0.04%
+22.6%
Q3 2022$1,577,000,000
+96352.6%
20,753
+7.3%
0.03%
-3.1%
Q2 2022$1,635,000
+12.6%
19,344
+16.9%
0.03%
+28.0%
Q1 2022$1,452,000
-99.9%
16,542
+16.9%
0.02%
+13.6%
Q4 2021$1,238,000,000
+96317.4%
14,154
-9.8%
0.02%
-15.4%
Q3 2021$1,284,000
-5.4%
15,698
+5.5%
0.03%
-10.3%
Q2 2021$1,358,000
+9.7%
14,884
+2.7%
0.03%
-3.3%
Q1 2021$1,238,000
-8.6%
14,486
+1.0%
0.03%
-21.1%
Q4 2020$1,354,000
+12.6%
14,339
+3.7%
0.04%
-5.0%
Q3 2020$1,202,000
+4.7%
13,823
+5.2%
0.04%
-7.0%
Q2 2020$1,148,000
+44.9%
13,139
+36.7%
0.04%
-35.8%
Q1 2020$792,000
-8.7%
9,610
+5.0%
0.07%
+86.1%
Q4 2019$867,000
+25.8%
9,156
+15.4%
0.04%
+9.1%
Q3 2019$689,000
+17.2%
7,933
+23.2%
0.03%
-50.0%
Q2 2019$588,000
+18.5%
6,440
+24.2%
0.07%
+144.4%
Q1 2019$496,000
+64.2%
5,186
+50.6%
0.03%
-41.3%
Q4 2018$302,000
+22.8%
3,443
+20.9%
0.05%
+17.9%
Q3 2018$246,000
+2.5%
2,848
-11.4%
0.04%
-7.1%
Q2 2018$240,0003,2150.04%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders